Qingyi Jia

Sichuan University — China

Medicine · Health Sciences

12h-index1.6kcitations29works7.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Adipose Tissue and Metabolism(5), Liver Disease Diagnosis and Treatment(4), Liver physiology and pathology(3), Diet and metabolism studies(3), DNA Repair Mechanisms(2)

Publications29 total

Neuroplastin-55 is a receptor of Manf and protects against diet-induced obesity by promoting adipose browning
Proceedings of the National Academy of Sciences·2025Open Access
A two-pronged nanomedicine counteracts obesity by remodeling adipose niche
Journal of Controlled Release·2025
Obesity care in Chinese adults: from evidence to clinical practice
Precision Clinical Medicine·2025Open Access
Incidence, prevalence, and burden of type 2 diabetes in China: Trend and projection from 1990 to 2050
Chinese Medical Journal·2025· 18 citedOpen Access
Proteomic variation underlies the heterogeneous risk of metabolic dysfunction-associated steatotic liver disease for subsequent chronic diseases
European Journal of Endocrinology·2025· 3 citedOpen Access
Adipose tissue-targeting nanomedicines for obesity pharmacotherapy
Trends in Endocrinology and Metabolism·2025· 14 cited
Comparative Effects of Obesity Medications for Adults Living with Obesity: A Systematic Review and Network Meta-Analysis
SSRN Electronic Journal·2025Open Access
Commentary: Shared decision making for weight‐lowering medications in China
Clinical and Translational Medicine·2024· 3 citedOpen Access
B3galt5 functions as a PXR target gene and regulates obesity and insulin resistance by maintaining intestinal integrity
Nature Communications·2024· 15 citedOpen Access
The Dual‐Target Nanoparticles with ROS Sensitivity Inhibit the Hedgehog Signaling Pathway and Decrease Oxidative Stress in Activated Hepatic Stellate Cells to Alleviate Liver Fibrosis
Advanced Functional Materials·2024· 18 citedOpen Access
Reactive Oxygen Species-Responsive Delivery of a Notch Inhibitor to Alleviate Nonalcoholic Steatohepatitis by Inhibiting Hepatic <i>de Novo</i> Lipogenesis and Inflammation
Molecular Pharmaceutics·2024· 6 cited
Development of a core outcome set for cardiovascular diabetology: a methodological framework
Frontiers in Endocrinology·2023· 2 citedOpen Access
Glutaredoxin-1 alleviates acetaminophen-induced liver injury by decreasing its toxic metabolites
Journal of Pharmaceutical Analysis·2023· 10 citedOpen Access
Mechanisms and applications of adipose-derived stem cell-extracellular vesicles in the inflammation of wound healing
Frontiers in Immunology·2023· 38 citedOpen Access
CREKA-modified liposomes target activated hepatic stellate cells to alleviate liver fibrosis by inhibiting collagen synthesis and angiogenesis
Acta Biomaterialia·2023· 25 cited
Dually fibronectin/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosis
Biomaterials·2023· 34 cited
Glutaredoxin 1 regulates cholesterol metabolism and gallstone formation by influencing protein S-glutathionylation
Metabolism·2023· 17 cited
The Function of Xenobiotic Receptors in Metabolic Diseases
Drug Metabolism and Disposition·2022· 9 cited
Influence of Free Fatty Acid Concentrations and Weight Loss on Adipose Tissue Direct Free Fatty Acid Storage Rates
The Journal of Clinical Endocrinology & Metabolism·2021· 2 citedOpen Access
Adipose tissue macrophage burden, systemic inflammation, and insulin resistance
American Journal of Physiology-Endocrinology and Metabolism·2020· 42 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Yanping Li(11), Jinhan He(11), Jinhang Zhang(8), Qinhui Liu(8), Yimin Xiong(7), Xiandan Jing(6), Qin Tang(5), Zijing Zhang(5), Jiahao Chen(5), Yonggang Zhang(5), Michael D. Jensen(4), Sheyu Li(4), Qing He(4), Jiqiao Yang(4), Haiying Song(3), Jiahui Li(3), Liang Du(3), Tian‐Yuan Xiong(3), Jiani Shen(3), Jingwei Li(3)